JAMA Oncology
Q1 Journal
Journal
Country
United States
Northern America
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Cancer Research
Q1
└
Oncology
Q1
Publisher
SJR 2025
7.399
Q1
SJR Score
H-Index
208
Citations / Doc (2yr)
9.16
Total Docs. (latest)
308
Total Citations (3yr)
9,717
Publication type
Journals
ISSN
23742445, 23742437
Coverage
2015-2026
Journal Rank
#152
Subject Categories
Cancer Research
Q1
Oncology
Q1
Subject Areas
Aims & Scope
JAMA Oncology is committed to publishing influential original research, opinions, and reviews that advance the science of oncology and improve the clinical care of patients with cancer.
Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers.
JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community.
Our goal is that successful communication of new knowledge will ultimately translate to clinical benefit for people living with and surviving cancer
Abstracting & Indexing
Scopus
Google Scholar
Web of Science
Medline
Embase
Detailed Metrics
| Total Docs. (latest) | 308 |
| Total Docs. (3 years) | 1,078 |
| Total Refs. | 4,823 |
| Total Citations (3 years) | 9,717 |
| Citable Docs. (3 years) | 546 |
| Citations / Doc. (2 years) | 9.16 |
| Ref. / Doc. | 15.66 |
| % Female | 41.3% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.